Bladder cancer trials in China

In China 167 Also abroad 626

167 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin
Where
Beijing, Changsha, Chengdu, Chongqing, Fuzhou, Hangzhou, Jinan, Nanjing, Shanghai, Shenyang, Tianjin, Wenzhou, Wuhan
Age
18 years and over
People
16
Run by
Lepu Biopharma Co., Ltd.
See details and how to joinNCT07283835
Phase 1Enrolling by invitation
Propranolol With Tislelizumab Plus GC in Neoadjuvant Bladder UC
Where
Guangzhou
Age
18 years and over
People
12
Run by
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT07353294
No phaseTaking people
Detecting CREPT in Urine for Bladder Cancer Diagnosis and Monitoring
Where
Beijing
Age
18 years to 75 years
People
250
Run by
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07514897
Phase 2Taking people
Trastuzumab in Combination With Serplulimab and Chemotherapy for the Treatment of HER2-overexpressing Unresectable Locally Advanced or Metastatic Biliary Tract Cancer or Urothelial Carcinoma After Failure of Standard Therapy
Where
Shenyang
Age
18 years to 85 years
People
20
Run by
Xiujuan Qu
See details and how to joinNCT07506057
Phase 1Taking people
Dual-Target Nectin-4/HER2 CAR-NK Cells in Advanced Urothelial Carcinoma
Where
Shenzhen
Age
18 years to 75 years
People
42
Run by
Beijing Biotech
See details and how to joinNCT07492628
Phase 2Not yet taking people in China
Probiotics Combined With Targeted Therapy Plus Immunotherapy in Bladder-Preserving Setting for Patients With MIBC
Where
Guangzhou
Age
18 years and over
People
146
Run by
chenxu
See details and how to joinNCT07474064
No phaseEnrolling by invitation
Artificial Intelligence-assisted HER2 Expression Assessment in Urothelial Carcinoma Based on Imaging-pathology Omics
Where
Beijing
Age
18 years and over
People
4,000
Run by
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07454941
No phaseTaking people
Nectin-4 Specific LMW PET Probe Imaging in Urothelial Carcinoma
Where
Beijing
Age
18 years to 75 years
People
20
Run by
Peking University Cancer Hospital & Institute
See details and how to joinNCT05321316
No phaseTaking people
The Guiding Value of Liquid Biopsy Based on Urinary Tumor DNA/RNA in the Second Transurethral Resection of High-risk Non-muscle Invasive Bladder Cancer
Where
Tianjin
Age
18 years and over
People
60
Run by
Tianjin Medical University Second Hospital
See details and how to joinNCT07130578
No phaseTaking people
Using Liquid Biopsy Testing to Identify, Monitor, Predict Recurrence in Urothelial Carcinoma
Where
Tianjin
Age
18 years and over
People
300
Run by
Tianjin Medical University Second Hospital
See details and how to joinNCT07441499
No phaseTaking people
Multiplex Mutation Detection Using Mass Spectrometry in Bladder Cancer
Where
Lanzhou
Age
18 years and over
People
400
Run by
Zhilong Dong
See details and how to joinNCT07424560
Phase 1/2Taking people
EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors
Where
Beijing
People
83
Run by
Essen Biotech
See details and how to joinNCT07410676
Phase 2Not yet taking people in China
NECTAR Study: Neoadjuvant Toripalimab + 9MW2821 for Local UTUC
Where
Beijing
Age
18 years to 80 years
People
40
Run by
Peking University Third Hospital
See details and how to joinNCT07412171
No phaseTaking people
Evaluation of Postoperative Adjuvant Chemotherapy Efficacy for Bladder Cancer Based on Organoid Technology.
Where
Jinan
Age
18 years to 80 years
People
266
Run by
Qilu Hospital of Shandong University
See details and how to joinNCT07379255
No phaseTaking people
Evaluation of the Efficacy of Anti-HER2 Antibody-Drug Conjugates (ADC) in Locally Advanced or Metastatic Bladder Cancer Based on Organoid Technology.
Where
Jinan
Age
18 years to 80 years
People
224
Run by
Qilu Hospital of Shandong University
See details and how to joinNCT07379268
No phaseTaking people
Evaluating the Efficacy of Neoadjuvant Chemotherapy Drugs Based on Organoid Technology
Where
Jinan
Age
18 years to 80 years
People
254
Run by
Qilu Hospital of Shandong University
See details and how to joinNCT07379281
Phase 1Taking people
Safety, Tolerability, and Preliminary Efficacy of KD01 Via Intravesical Instillation in Bladder Cancer (BC)
Where
Wuhan
Age
18 years to 75 years
People
29
Run by
Tongji Hospital
See details and how to joinNCT07359235
No phaseTaking people
Adaptive Radiotherapy for Genitourinary Cancers
Where
Beijing
Age
18 years and over
People
60
Run by
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07324798
No phaseTaking people
Establishment and Promotion of an AI-Based Early Warning System for Prostate and Bladder Cancer Screening in the Male Community Population of Beijing
Where
Beijing
Age
18 years to 85 years
People
3,000
Run by
Peking University First Hospital
See details and how to joinNCT07319923
Phase 2Taking people
9MW2821 Combined With Toripalimab in Perioperative Patients With Urothelial Cancer
Where
Guangzhou
Age
18 years and over
People
90
Run by
Mabwell (Shanghai) Bioscience Co., Ltd.
See details and how to joinNCT07314723
No phaseTaking people
Adjuvant Radioimmunotherapy Compared With Adjuvant Chemotherapy for UTUC
Where
Beijing
Age
18 years and over
People
178
Run by
Peking University First Hospital
See details and how to joinNCT06120374
Phase 2Taking people
Neoadjuvant Zanidatamab + Tislelizumab + Chemotherapy for Selective Bladder Preservation in HER2-Positive MIBC
Where
Fuzhou, Hangzhou, Jinan, Nanchang, Putian, Quanzhou, Sanming, Shanghai, Wenzhou, Xiamen, Zhangzhou
Age
18 years to 85 years
People
25
Run by
Fujian Medical University Union Hospital
See details and how to joinNCT07296705
Phase 2Taking people
A Clinical Study of the Efficacy and Safety of Disitamab Vedotin in Combination With Radiotherapy for the Adjuvant Treatment of HER2 Overexpressing UTUC Patients With High Risk Factors for Recurrence After Radical Surgery
Where
Beijing
Age
18 years and over
People
60
Run by
Peking University First Hospital
See details and how to joinNCT06210490
No phaseTaking people
Circulating and Urine Tumor DNA Dynamics Predict Minimal Residual Disease and Recurrence Risk in Locally Advanced Upper Tract Urothelial Carcinoma
Where
Shanghai
Age
18 years and over
People
84
Run by
RenJi Hospital
See details and how to joinNCT05595408
Phase 2Taking people
Combination of DV and Tislelizumab for Renal Preservation in High-risk UTUC Patients
Where
Shanghai
Age
18 years to 90 years
People
20
Run by
RenJi Hospital
See details and how to joinNCT05912816